These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 3348843

  • 1. Influence of etofibrate on low density lipoprotein metabolism.
    Series JJ, Caslake MJ, Kilday C, Cruickshank A, Demant T, Packard CJ, Shepherd J.
    Atherosclerosis; 1988 Feb; 69(2-3):233-9. PubMed ID: 3348843
    [Abstract] [Full Text] [Related]

  • 2. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I, Koller E, Li S, Yang Q, Banyai M, Rauscha F, Pidlich J, Pirker W, Sinzinger H.
    Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
    [Abstract] [Full Text] [Related]

  • 3. Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate.
    Mordasini R, Riesen W, Oster P, Keller M, Middelhoff G, Lang PD.
    Atherosclerosis; 1981 Oct; 40(2):153-8. PubMed ID: 6796096
    [Abstract] [Full Text] [Related]

  • 4. Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects.
    Stewart JM, Packard CJ, Lorimer AR, Boag DE, Shepherd J.
    Atherosclerosis; 1982 Sep; 44(3):355-65. PubMed ID: 6293516
    [Abstract] [Full Text] [Related]

  • 5. [Bezafibrate and delayed action etofibrate in hyperlipidemia].
    Lang PD, Vollmar J.
    Dtsch Med Wochenschr; 1983 Feb 25; 108(8):302-5. PubMed ID: 6825604
    [No Abstract] [Full Text] [Related]

  • 6. Bezafibrate treatment in primary hypercholesterolaemia. Possibility of intermittent treatment.
    Fringes B, Riede UN, von Deimling O.
    Atherosclerosis; 1982 Sep 25; 44(3):391-2. PubMed ID: 7150401
    [No Abstract] [Full Text] [Related]

  • 7. [Study of the antilipemic effect of etofibrate (Lipo-Merz)].
    Słowińska R, Bochenek W, Unlot J.
    Pol Tyg Lek; 1983 Apr 25; 38(17):529-32. PubMed ID: 6356087
    [No Abstract] [Full Text] [Related]

  • 8. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
    Machalke K, Djaja S, Richter E.
    Ther Ggw; 1982 May 25; 121(5):301-11. PubMed ID: 6953613
    [No Abstract] [Full Text] [Related]

  • 9. [Atherosclerosis treatment with etofibrate retard. New perspectives].
    Degenring FH, Schatton W, Hotz W.
    Fortschr Med; 1983 Aug 11; 101(30):1391-6. PubMed ID: 6618402
    [Abstract] [Full Text] [Related]

  • 10. [The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa (author's transl)].
    Mertz DP, Loewer H, Suermann I.
    Med Klin; 1979 Dec 21; 74(51-52):1953-6. PubMed ID: 542179
    [Abstract] [Full Text] [Related]

  • 11. Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
    Olsson AG, Orö L.
    Atherosclerosis; 1982 Apr 21; 42(2-3):229-43. PubMed ID: 6951582
    [Abstract] [Full Text] [Related]

  • 12. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
    Prager R, Schernthaner G, Kostner GM, Mühlhauser I, Zechner R, Dorda W.
    Atherosclerosis; 1982 Jun 21; 43(2-3):321-7. PubMed ID: 6810904
    [Abstract] [Full Text] [Related]

  • 13. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC, Austin MA, Moulin P, Wolf AC, Cryer D, Knopp RH.
    Atherosclerosis; 1993 Aug 21; 102(1):107-19. PubMed ID: 8257447
    [Abstract] [Full Text] [Related]

  • 14. [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].
    Dembińska-Kieć A, Kostka-Trabka E, Grodzińska L, Bieroń K, Kedzior A, Basista M, Zmuda A, Trabka E, Slawiński M, Czarnecka H.
    Fortschr Med; 1989 Jul 10; 107(20):450-2. PubMed ID: 2767596
    [Abstract] [Full Text] [Related]

  • 15. Treatment of familial hypercholesterolemia with a combination of bezafibrate and guar.
    Wirth A, Middelhoff G, Braeuning C, Schlierf G.
    Atherosclerosis; 1982 Dec 10; 45(3):291-7. PubMed ID: 7159500
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
    Seplowitz AH, Smith FR, Berns L, Eder HA, Goodman DS.
    Atherosclerosis; 1981 Apr 10; 39(1):35-43. PubMed ID: 7018502
    [Abstract] [Full Text] [Related]

  • 17. Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects.
    Sposito AC, Mansur AP, Maranhão RC, Rodrigues-Sobrinho CR, Coelho OR, Ramires JA.
    Braz J Med Biol Res; 2001 Feb 10; 34(2):177-82. PubMed ID: 11175492
    [Abstract] [Full Text] [Related]

  • 18. Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters.
    Vessby B, Lithell H, Hellsing K, Ostlund-Lindqvist AM, Gustafsson IB, Boberg J, Ledermann H.
    Atherosclerosis; 1980 Oct 10; 37(2):257-69. PubMed ID: 7000090
    [No Abstract] [Full Text] [Related]

  • 19. Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemia.
    Geiss HC, Dietlein M, Parhofer KG.
    Exp Clin Endocrinol Diabetes; 2003 Sep 10; 111(6):322-4. PubMed ID: 14520596
    [Abstract] [Full Text] [Related]

  • 20. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE, Walden CE, Hunninghake DB, Hill-Williams D, Knopp RH.
    Am J Cardiol; 1995 Jul 13; 76(2):129A-135A. PubMed ID: 7604788
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.